BLEND THERAPEUTICS Trademark

Trademark Overview


On Monday, September 15, 2014, a trademark application was filed for BLEND THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the BLEND THERAPEUTICS trademark a serial number of 86394559. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 13, 2016. This trademark is owned by Blend Therapeutics, Inc.. The BLEND THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, antineoplastics, anti-inflammatories, anti-infectives, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals, cardiovascular pharmaceuticals, dermatological pharmaceutical products, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the treatment and prevention of diseases and disorders of the auto-immune system, the metabolic system, the musculo-skeletal system and the genitourinary system, pharmaceutical preparations for use in hematology and in tissue and organ transplantation, pharmaceutical preparations for the treatment of eye diseases and conditions, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations for the treatment of ki...

Pharmaceutical research and development
blend therapeutics

General Information


Serial Number86394559
Word MarkBLEND THERAPEUTICS
Filing DateMonday, September 15, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 13, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 15, 2015

Trademark Statements


Goods and ServicesPharmaceuticals, namely, antineoplastics, anti-inflammatories, anti-infectives, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals, cardiovascular pharmaceuticals, dermatological pharmaceutical products, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the treatment and prevention of diseases and disorders of the auto-immune system, the metabolic system, the musculo-skeletal system and the genitourinary system, pharmaceutical preparations for use in hematology and in tissue and organ transplantation, pharmaceutical preparations for the treatment of eye diseases and conditions, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations for the treatment of immune system related diseases and disorders, pharmaceutical preparations for the treatment of kidney diseases, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating hypertension, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for use in urology, pharmaceutical products for ophthalmological use, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical products for the treatment of bone diseases, pharmaceutical products for treating respiratory diseases, pharmaceutical products for treating respiratory diseases and asthma, pharmaceutical preparations for the treatment of sleep disorders and neurological disorders; nano-particles, namely, those composed of polymers, therapeutics, or excipients used for medical diagnostic purposes and for the treatment of cancer, inflammation, cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, infectious diseases, diabetes, impotence, obesity, arthritis and autoimmune disorders; pharmaceuticals and medicines containing nano-particles, for use for the prevention and/or treatment of cancer, cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, infectious diseases, diabetes, impotence, obesity, arthritis and autoimmune disorders, and for use as drug delivery agents consisting of substances that facilitate delivery of a wide range of pharmaceuticals allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cancer, cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, infectious diseases, diabetes, impotence, obesity, arthritis and autoimmune disorders; vaccines incorporating nano-particles
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 22, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 22, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTVA (ABC), LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressWILMINGTON, DE 19801

Party NameBlend Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Party NameBlend Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events


Event DateEvent Description
Wednesday, May 11, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, June 13, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 13, 2016ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 18, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 18, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 10, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 15, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 15, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 26, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 10, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 10, 2015ASSIGNED TO LIE
Tuesday, July 28, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 7, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 6, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 6, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 6, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 6, 2015NON-FINAL ACTION E-MAILED
Tuesday, January 6, 2015NON-FINAL ACTION WRITTEN
Monday, December 29, 2014ASSIGNED TO EXAMINER
Monday, September 22, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 18, 2014NEW APPLICATION ENTERED IN TRAM